Maryland House Bill 1132

---

Spectrum: Partisan Bill (Republican 6-0)
Status: Introduced on February 7 2024 - 25% progression
Action: 2024-03-04 - Withdrawn by Sponsor
Text: Latest bill text (Introduced) [PDF]

Authorizing pharmaceutical manufacturers and representatives of pharmaceutical manufacturers to engage in the truthful promotion of off-label uses for drugs, biological products, and devices; and prohibiting certain persons from taking certain enforcement and disciplinary action against a pharmaceutical manufacturer, representative of a pharmaceutical manufacturer, or health care provider for engaging in a truthful promotion of an off-label use of a drug, biological product, or device.

Drugs, Biological Products, and Devices - Off-Label Use - Promotion

Del. Matt Morgan [R]	Del. Lauren Arikan [R]	Del. Brian Chisholm [R]	Del. Robin Grammer [R]
Del. Susan McComas [R]	Del. Ryan Nawrocki [R]

Date	Chamber	Action
2024-03-04	House	Withdrawn by Sponsor
2024-02-28	House	Hearing canceled
2024-02-09	House	Hearing 2/29 at 1:00 p.m.
2024-02-07	House	First Reading Health and Government Operations

Chapter	Article	Section	Citation Type	Statute Text
Health - General	21	218.1	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1132?ys=2024RS
Text	https://mgaleg.maryland.gov/2024RS/bills/hb/hb1132f.pdf
Supplement	https://mgaleg.maryland.gov/2024RS/votes_comm/hb1132_hgo.pdf